AbbVie
ABBV
4,263 hedge funds and large institutions have $338B invested in AbbVie in 2026 Q2 according to their latest regulatory filings, with 286 funds opening new positions, 1,941 increasing their positions, 1,559 reducing their positions, and 112 closing their positions.
155% more first-time investments, than exits
New positions opened: 286 | Existing positions closed: 112
101% more capital inflows, than outflows
Capital inflows: $22.4B | Capital outflows: $11.1B
25% more repeat investments, than reductions
Existing positions increased: 1,941 | Existing positions reduced: 1,559
20% more call options, than puts
Call options by funds: $3.81B | Put options by funds: $3.17B
15% more funds holding in top 10
Funds holding in top 10: 175 → 201 (+26)
3% more funds holding
Funds holding: 4,138 → 4,263 (+125)
2.56% more ownership
Funds ownership: 73.5% → 76.06% (+2.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.89B |
| 2 |
Franklin Resources
San Mateo,
California
|
+$1.16B |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$718M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$643M |
| 5 |
SG Americas Securities
New York
|
+$613M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.91B |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$581M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$403M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$396M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$353M |
ABBV Hedge Fund Activity: Q2 2026 in Review
4,263 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2026, worth a combined $338B — up 20% from $282B a quarter earlier.
Buyers outnumbered sellers: 286 funds opened new ABBV positions and 112 closed out — a net gain of 174 holders — while 1,941 added to existing stakes and 1,559 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $1.89B. The largest seller was JP Morgan Chase, cutting an estimated $1.91B.
- 4,263 institutional investors held AbbVie (ABBV) as of Q2 2026, up from 4,138 in Q1 2026.
- Funds reported $338B of AbbVie stock for Q2 2026, up 20% quarter-over-quarter.
- 286 funds opened new AbbVie positions in Q2 2026 and 112 closed out, a net change of +174 holders.
- The largest AbbVie buyer in Q2 2026 was Royal Bank of Canada, an estimated $1.89B added.
- The largest AbbVie seller in Q2 2026 was JP Morgan Chase, an estimated $1.91B sold.
Based on aggregated 13F filings for Q2 2026.